Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction

被引:0
|
作者
Todd, Jamie L. [1 ,2 ]
Weber, Jeremy M. [2 ]
Kelly, Francine L. [1 ]
Nagler, Andrew [1 ]
Mcarthur, Patrick
Eason, Lerin [1 ]
Rim, Jeeyon G. [1 ]
Frankel, Courtney W. [1 ]
Belperio, John A. [3 ]
Budev, Marie [4 ]
Martinu, Tereza [5 ,6 ,7 ]
Patel, Kunal [8 ]
Reynolds, John M. [1 ]
Shah, Pali D. [9 ]
Singer, Lianne G. [5 ,6 ,7 ]
Snyder, Laurie D. [1 ,2 ]
Tsuang, Wayne [4 ]
Weigt, S. Sam [3 ]
Neely, Megan L. [2 ,10 ]
Palmer, Scott M. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA
[4] Cleveland Clin, Dept Med, Cleveland, OH USA
[5] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Univ Hlth Network, Ajmera Transplant Ctr, Toronto Lung Transplant Program, Toronto, ON, Canada
[8] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
[9] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[10] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
来源
基金
美国国家卫生研究院;
关键词
lung transplantation; chronic lung allograft dysfunction; hyaluronan; bronchoalveolar lavage fluid;
D O I
10.1016/j.healun.2024.10.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Few tools exist for the early identification of patients at risk for chronic lung allograft dysfunction (CLAD). We previously showed hyaluronan (HA), a matrix molecule that regulates lung inflammation and fibrosis, accumulates in bronchoalveolar lavage fluid (BALF) and blood in CLAD. We aimed to determine if early posttransplant HA elevations inform CLAD risk. METHODS: HA was quantified in 3,080 BALF and 1,323 blood samples collected over the first posttransplant year in 743 adult lung recipients at 5 centers. The relationship between BALF or blood HA and CLAD was assessed using Cox models with a time-dependent binary covariate for "elevated" HA. Potential thresholds for elevated HA were examined using a grid search between the 50th and 85th percentile. The optimal threshold was identified using fit statistics, and the association between the selected threshold and CLAD was internally validated through iterative resampling. A multivariable Cox model using the selected threshold was performed to evaluate the association of elevated HA with CLAD, considering other factors that may influence CLAD risk. RESULTS: BALF HA levels > 19.1 ng/ml (65th percentile) had the largest hazard ratio (HR) for CLAD (HR 1.70, 95% confidence interval [CI] 1.25-1.31; p < 0.001), optimized fit statistics, and demonstrated robust reproducibility. In a multivariable model, the occurrence of BALF HA > 19.1 ng/ml in the first posttransplant year conferred a 66% increase in the hazards for CLAD (adjusted HR 1.66, 95% CI 1.19-2.32; p = 0.003). Blood HA was not significantly associated with CLAD. CONCLUSIONS: We identified and validated a precise threshold for BALF HA in the first post- transplant year that distinguishes patients at increased CLAD risk. J Heart Lung Transplant 2025;44:320-328 (c) 2024 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:320 / 328
页数:9
相关论文
共 50 条
  • [21] Tuberculosis as a Risk Factor for Early Chronic Lung Allograft Dysfunction - An Indian Experience
    Priyaranjan, S.
    Rahulan, V.
    Tisekar, O.
    Lalani, M.
    Negigowda, M.
    Shah, U.
    Dutta, P.
    Attawar, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S474 - S474
  • [22] Expression of γ-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients
    Moudgil, A
    Bagga, A
    Toyoda, M
    Nicolaidou, E
    Jordan, SC
    Ross, D
    CLINICAL TRANSPLANTATION, 1999, 13 (02) : 201 - 207
  • [23] Dynamic Contrast-Enhanced Lung MRI in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
    Pierre-Louis, M. Hill
    Susnjar, A.
    Allison, M.
    Akinniyi, A.
    Zhou, I. Y.
    Montesi, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [24] The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction
    Shino, M. Y.
    Weigt, S. S.
    Li, N.
    Derhovanessian, A.
    Sayah, D. M.
    Saggar, R.
    Huynh, R. H.
    Gregson, A. L.
    Ardehali, A.
    Ross, D. J.
    Lynch, J. P., III
    Elashoff, R. M.
    Belperio, J. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (01) : 136 - 144
  • [25] Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction
    Harms, Anja
    Fuehner, Thomas
    Warnecke, Gregor
    Haverich, Axel
    Gottlieb, Jens
    Trummer, Arne
    TRANSPLANTATION, 2015, 99 (11) : 2394 - 2400
  • [26] BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk A Multicenter Study
    Todd, Jamie L.
    Weber, Jeremy M.
    Kelly, Francine L.
    Neely, Megan L.
    Mulder, Hillary
    Frankel, Courtney W.
    Nagler, Andrew
    Mccrae, Christopher
    Newbold, Paul
    Kreindler, Jim
    Palmer, Scott M.
    CHEST, 2023, 164 (03) : 670 - 681
  • [27] Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients
    Zhang, Dan
    Wang, Xiaoxing
    Du, Wenwen
    Qin, Wei
    Chen, Wenqian
    Zuo, Xianbo
    Li, Pengmei
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [28] Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
    Holz, Olaf
    Kueppers, Lucas
    Gottlieb, Jens
    Greer, Mark
    Hohlfeld, Jens
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] Non-HLA Antibodies Are Associated with Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
    Vyskocilova, K.
    Roder, M.
    Vychytilova, K.
    Glosova, A.
    Zajacova, A.
    Kotowski, T.
    Dutkova, A.
    Fila, L.
    Lischke, R.
    Slavcev, A.
    Havlin, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S133 - S134
  • [30] Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction
    Iasella, C. J.
    Snyder, M.
    Popescu, I.
    Wei, J.
    Hoji, A.
    Zhang, Y.
    Xu, W.
    Iouchmanov, V.
    Brown, M.
    Lendermon, E.
    Johnson, B.
    Kilaru, S.
    Morrell, M.
    Pilewski, J.
    Greenland, J.
    Chen, K.
    McDyer, J. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S57 - S58